PRASH 12 recalled over sterility concerns
- Recall date
- July 25, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Ranier's Compounding Laboratory recalls PRASH 12.2mcg/1.22m/19.29 (Prostaglandin/Phentolamine/Papaverine) Injection, 10 mL vial, Rx only, Ranier's Rx Laborator…
- Recall number
- D-1091-2018
- FDA classification
- Class II
- Brand / firm
- Ranier's Compounding Laboratory
- Sold / distributed
- Product was distributed within the state of Pennsylvania.
Why it was recalled
Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
PRASH 12.2mcg/1.22m/19.29 (Prostaglandin/Phentolamine/Papaverine) Injection, 10 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.
Get recall alerts
Free email alert whenever Ranier's Compounding Laboratory has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Ranier's Compounding Laboratory